How has been the historical performance of Kingfa Science?

Answer:The historical performance of Kingfa Science shows a significant upward trend in net sales and profitability over the years.

Breakdown:
Kingfa Science has demonstrated robust growth in net sales, increasing from 701.52 Cr in March 2019 to 1,744.69 Cr in March 2025. This growth is accompanied by a rise in total operating income, which mirrors the sales trend, reaching 1,744.69 Cr in March 2025. The raw material costs have also escalated, from 556.37 Cr in March 2019 to 1,244.60 Cr in March 2025, reflecting the increased scale of operations. Operating profit, excluding other income, has improved significantly, rising from 34.92 Cr in March 2019 to 225.07 Cr in March 2025, with the operating profit margin increasing from 4.98% to 12.9% over the same period. Profit before tax has surged from 29.22 Cr in March 2019 to 206.08 Cr in March 2025, while profit after tax has followed suit, climbing from 19.06 Cr to 152.86 Cr. The earnings per share (EPS) have also seen a remarkable rise, from 15.74 in March 2019 to 126.23 in March 2025. On the balance sheet, total assets increased from 551.40 Cr in March 2019 to 994.44 Cr in March 2024, while total liabilities peaked at 1,010.33 Cr in March 2023 before reducing to 994.44 Cr in March 2024. Cash flow from operating activities has fluctuated but ended positively with a net cash inflow of 2.00 Cr in March 2024, compared to a net outflow of 6.00 Cr in March 2023. Overall, Kingfa Science has shown a strong upward trajectory in both revenue and profitability metrics over the years.